Alyssa Farah Griffin told The View that Operation Warp Speed, the Trump administration program that propelled Covid-19 vaccine development and distribution, was “unquestionable” and “one of Donald Trump’s greatest successes,” and that he should “take credit for it” and “lean into it.” The remarks came as the daytime panel weighed lingering vaccine skepticism in the United States and the political dimensions of the vaccination effort.
During their Hot Topics discussion, Griffin referenced a clip from a Senate hearing in which Debra Houry, a physician testifying before Sen. Bernie Sanders, called Warp Speed “a godsend for this country” that “saved millions of lives.” The program, created to accelerate the development, manufacturing and distribution of vaccines, helped bring Covid-19 shots to market faster than standard timelines and became a defining feature of the federal government’s pandemic response. Griffin argued that credit for the program belongs with Trump, arguing that the administration’s work should be acknowledged even as political narratives evolve around vaccines.
The conversation underscored broader questions about public trust in vaccines as a political minefield. Behar pressed why pharmaceutical companies have not been more active in raising awareness about vaccines, prompting a first instinct from Haines that doctors should lead the messaging rather than industry spokespeople. The exchange touched on a longer-running tension: how to frame federal success in a way that resonates with diverse political audiences while avoiding alienating parts of Trump’s base.
Griffin also noted that recent polls show Americans’ trust in vaccines remains mixed. While confidence in vaccines that have existed for decades persists with a solid portion of the public, trust in newer vaccines and in pharmaceutical companies has waned in some demographics. She cited that a majority of the country still supports the long-trusted vaccines that have been part of routine immunization for decades, even as skepticism persists about new products and the pharmaceutical industry’s role in public health campaigns.
The discussion reflected how vaccine policy has become a focal point in American political discourse. Behar’s questions about who should be the public-facing champions of vaccination—doctors or industry groups—highlight ongoing debates about how to communicate scientific information in a polarized environment. Griffin’s insistence that Trump should be credited for Warp Speed signals how political figures seek to corral credit for public-health milestones, even as voters weigh risk perceptions and the quality of information available.
Overall, the segment illustrates the continuing intersection of health policy and politics in the United States, where a historic, rapid vaccine development program remains a topic of partisan framing and a test of how elected leaders and public figures navigate responsibility, credit, and public trust. The View airs on weekdays at 11/10c on ABC.